About PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)
During the past decade, PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis
2016-10-01
2017-08-01
Completed
74
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
2018-03-07
2019-02-05
Completed
385
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
2018-07-13
2020-09-09
Terminated
484
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
2018-05-01
2018-10-08
Completed
116
A Study Evaluating the Long-term Safety of VX-445 Combination Therapy
2019-08-09
2022-12-14
Completed
458
A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
2019-08-28
2020-06-12
Completed
271
Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy
2019-12-05
2022-12-16
Completed
251
A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)
2021-01-18
2022-07-14
Completed
69
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)
According to Clinical.Site data, the most researched conditions in "PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)" are
"Esophageal Neoplasms" (2 trials). Many other conditions were trialed in "PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)" in a lesser frequency.
Clinical Trials Intervention Types at PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)
Most popular intervention types in "PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "5-FU" (2 trials), "Cisplatin" (2 trials), "Pembrolizumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)
The vast majority of trials in "PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)" are
2 trials for "All" genders.
Clinical Trials Status at PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)
Currently, there are NaN active trials in "PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110)".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".